AU2670995A - New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness - Google Patents

New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Info

Publication number
AU2670995A
AU2670995A AU26709/95A AU2670995A AU2670995A AU 2670995 A AU2670995 A AU 2670995A AU 26709/95 A AU26709/95 A AU 26709/95A AU 2670995 A AU2670995 A AU 2670995A AU 2670995 A AU2670995 A AU 2670995A
Authority
AU
Australia
Prior art keywords
antigen
compounds
specific
new methods
selective modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26709/95A
Other languages
English (en)
Inventor
Serge Barcy
Mark De Boer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Publication of AU2670995A publication Critical patent/AU2670995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26709/95A 1994-05-26 1995-05-26 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness Abandoned AU2670995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94870088 1994-05-26
EP94870088 1994-05-26
PCT/EP1995/002012 WO1995032734A1 (fr) 1994-05-26 1995-05-26 Nouveaux procedes et composes destines a la modulation selective de la reaction des lymphocytes t specifiques d'un l'antigene

Publications (1)

Publication Number Publication Date
AU2670995A true AU2670995A (en) 1995-12-21

Family

ID=8218641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26709/95A Abandoned AU2670995A (en) 1994-05-26 1995-05-26 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Country Status (4)

Country Link
EP (1) EP0759782A1 (fr)
AU (1) AU2670995A (fr)
CA (1) CA2188812A1 (fr)
WO (1) WO1995032734A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08333262A (ja) * 1995-04-07 1996-12-17 Chugai Pharmaceut Co Ltd 免疫抑制剤
GB9516760D0 (en) * 1995-08-16 1995-10-18 Sandoz Ltd Organic compounds
US6319906B1 (en) 1996-12-31 2001-11-20 Isis Pharmaceuticals Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7235653B2 (en) 1996-12-31 2007-06-26 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6077833A (en) * 1996-12-31 2000-06-20 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
EP1046651A1 (fr) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition et méthode pour moduler l'interaction des cellules dendritiques et les cellules T
DK1224264T3 (da) * 1999-10-15 2010-05-10 Baylor Res Inst Anvendelse af allogene cellelinjer til at belaste antigenpræsenterende celler til at fremkomme med immunresponser
EP1118331A1 (fr) * 2000-01-21 2001-07-25 I.D.M. Immuno-Designed Molecules Méthode pour augmenter la présentation d'antigène exogène par les cellules humaines présentatrices d'antigène et complexes de microparticules opsonisées pour appliquer cette méthode
WO2003066095A2 (fr) * 2002-02-07 2003-08-14 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Modulation de tolerance par modulation de signalisation de recepteur fc$g(g)riib
GB0212701D0 (en) * 2002-05-31 2002-07-10 Imp College Innovations Ltd Immunoliposomes
AU2003278541A1 (en) 2002-09-20 2004-04-08 Stichting Katholieke Universiteit Method of treating rheumatoid arthritis by interfering with expression of dc-sign by macrophages and diagnosis thereof
WO2004026326A2 (fr) 2002-09-20 2004-04-01 Stichting Katholieke Universiteit Recepteur de capture d'antigene de candida albicans sur les cellules dendritiques
EP1462111A1 (fr) * 2003-03-28 2004-09-29 Universiteit Utrecht Holding B.V. Composition pour l'induction d'immunotolérance
US20040219143A1 (en) * 2003-04-30 2004-11-04 Bluth Martin Heath Methods for recombinant immunoglobulin treatment
US7897582B2 (en) 2003-05-23 2011-03-01 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7960355B2 (en) 2003-05-23 2011-06-14 Isis Pharmaceuticals, Inc. Compositions and methods for the modulation of the expression of B7 protein
WO2005058244A2 (fr) 2003-12-15 2005-06-30 Alexion Pharmaceuticals, Inc. Nouveaux anticorps anti-dc-sign

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
DE3711724A1 (de) * 1987-04-07 1988-10-20 Harro Boerner Medizinische Kom System zum einwirken auf, insbesondere zerstoeren von viren
GB9009106D0 (en) * 1990-04-23 1990-06-20 3I Res Expl Ltd Processes and intermediates for synthetic antibody derivatives
US5641875A (en) * 1993-09-30 1997-06-24 University Of Pennsylvania DNA encoding chimeric IgG Fc receptor

Also Published As

Publication number Publication date
EP0759782A1 (fr) 1997-03-05
WO1995032734A1 (fr) 1995-12-07
CA2188812A1 (fr) 1995-12-07

Similar Documents

Publication Publication Date Title
AU6449798A (en) Apparatus and methods for the preparation of chemical compounds
AU4705697A (en) Systems and methods for the synthesis of organic compounds
AU1825197A (en) Parallel reaction cassette and associated devices
AU2670995A (en) New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness
IL116172A0 (en) Banding system banding tape and methods of using the same
AU5744296A (en) Breathable gas mixing device and methods
AU1650897A (en) Method for hair joining and hair-joining device used for the same
IL129389A0 (en) Compounds and methods for diagnsosis of tuberculosis
AU4339197A (en) Fastening device and method of use
AU2448797A (en) Methods of providing neuroprotection
AU2687797A (en) Suspended files
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU6842198A (en) Hair-treatment substance application
AU3371197A (en) Wrist-wear attachment device and method of use
AU9487098A (en) Methods and materials for control of termites
AU1718195A (en) Cholinesterase activator
AU6154698A (en) System and method for controlling the operation of toys
AU2500797A (en) Methods of modulating t-cell activation
AU1418895A (en) Carrying device
AU8287798A (en) Adsorption apparatus and methods
AU5932396A (en) Controlled release of pesticides with activated carbon
AUPM587694A0 (en) Chemically-set anchor system
AU736432C (en) Braking device with region controlled weakness
AU1901695A (en) Audio device
AU3488895A (en) Carrier device